text.skipToContent text.skipToNavigation

Maximum quantity allowed is 999

Please select the quantity

CAS RN: 93957-55-2 | Product Number: F0820

Fluvastatin Sodium Salt


Purity: >98.0%(HPLC)(N)
Synonyms:
Documents:
1G
₹8,800
3   Contact Us ≥20 
5G
₹16,300
1   1   2  

*Upon orders receipt, Hyderabad stocks will be dispatched on the same day & Chennai stocks will be dispatched in 3-6 working days.
*Items available in Japan warehouse will be dispatched in 10-12 working days.
*INR price is exclusive of domestic taxes applicable.
*Change currency to place order in USD.
*TCI frequently reviews storage conditions to optimize them. Please note that the latest information on the storage temperature for the products is described on our website.


Note:

Previously this product had been labeled as a hydrate form both in product name and molecular formula. The hydrate form had no exclusive CAS RN and used to share the same CAS RN as the anhydrous form.
To avoid any misleading information and since moisture in product is considered as an impurity, we have decided to remove the term 'Hydrate' from product name and 'xH2O' from the molecular formula for such products.
Please use it at ease since there is no difference in product quality, even if you see the previous indications on a part of label.

Product Number F0820
Purity / Analysis Method >98.0%(HPLC)(N)
Molecular Formula / Molecular Weight C__2__4H__2__5FNNaO__4 = 433.46  
Physical State (20 deg.C) Solid
Storage Temperature 0-10°C
Condition to Avoid Heat Sensitive
CAS RN 93957-55-2
Related CAS RN 93957-54-1
PubChem Substance ID 160870917
Merck Index (14) 4218
MDL Number

MFCD00929076

Specifications
Appearance Light orange to Yellow to Green powder to crystal
Purity(HPLC) min. 98.0 area%
Purity(with Total Nitrogen) min. 98.0 %(calcd.on anh.substance)
Water max. 6.0 %
Properties (reference)
Solubility (soluble in) Methanol
GHS
Related Laws:
RTECS# MJ9675100
Transport Information:
Application
Fluvastatin Sodium Salt: A HMG-CoA Reductase Inhibitor with Anti-Oxidative Properties

Enzyme HMG-CoA (3-hydroxy-3-methylglutaryl coenzyme A) reductase catalyzes the rate-limiting step in cholesterol biosynthesis. Statins inhibit the action of HMG-CoA reductase resulting in the reduction of low-density-lipoprotein (LDL) and total cholesterol levels. In addition, statins (in particular fluvastatin) have reported their anti-oxidative properties. Many statins are metabolized by cytochrome P450 3A4 (CYP3A4) while fluvastatin is metabolized by CYP2C9. (The product is for research purpose only.)

References


PubMed Literature


Documents (Note: Some products will not have analytical charts available.)
Safety Data Sheet (SDS)
Please select Language.

The requested SDS is not available.

Please Contact Us for more information.

Specifications
C of A & Other Certificates
Please enter Lot Number Incorrect Lot Number is entered
Analytical Charts
Please enter Lot Number Incorrect Lot Number is entered

The requested analytical chart is not available. Sorry for the inconvenience.

Other Documents